华仁药业(300110.SZ)：红塔创新拟减持不超1%的股份

Core Viewpoint - Huaren Pharmaceutical (300110.SZ) announced a plan for Red Tower Innovation to reduce its holdings by up to 1% of the company's total share capital, equating to a maximum of 11.82 million shares, within three months starting from August 26, 2025, to November 25, 2025, through centralized bidding transactions [1] Summary by Category - Company Announcement - Huaren Pharmaceutical has disclosed a share reduction plan involving Red Tower Innovation, which will take place over a specified period [1] - Share Reduction Details - The reduction will not exceed 1% of the total share capital, amounting to a maximum of 11.82 million shares [1] - The timeframe for this reduction is set from August 26, 2025, to November 25, 2025 [1] - The method of reduction will be through centralized bidding transactions [1]